Skip to content

Clinical trials

Phase 4 Urinary Tract Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Tract Infections Phase: Phase 4 Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20041
20051
20072
20082
20095
20102
20115
20125
20137
20146
20155
20168
20176
20187
20193
20207
20216
20223
20232
20244
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Unknown status17
Terminated13
Recruiting12
Withdrawn9
Active, not recruiting3
Suspended1
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Wake Forest University Health Sciences4
Rabin Medical Center3
University of California, San Francisco3
Assistance Publique - Hôpitaux de Paris2
University of British Columbia2
University of California, San Diego2
University of Oslo2
Women and Infants Hospital of Rhode Island2
Xiangbei Welman Pharmaceutical Co., Ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Tract Infections102
Infections6
Bacteriuria5
Escherichia coli Infections4
Bacterial Infections3
Cystitis3
Intraabdominal Infections3
Pneumonia3
Pneumonia, Ventilator-Associated3
Respiratory Tract Infections3

Trials

Showing 76 to 100 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.